Efficacy of Treadmill Walking With Hidden Vision for Rehabilitation in the Subacute Phase of Stroke
MAVREEC
1 other identifier
interventional
36
1 country
1
Brief Summary
Objective: The aim of this study is to compare the efficiency of vision-obscured versus vision-retained treadmill gait training in subacute post-stroke patients. Methodology: Thirty-six patients with stroke (ischemic or hemorrhagic) less than six months old will be included and randomized into two parallel groups. The experimental group will undergo treadmill gait training using an opaque mask, combined with body weight reduction (Lite Gait® harness). The control group will follow the same walking protocol, but with their eyes open. Each session will last 20 minutes, integrated into one hour of rehabilitation, at a rate of three sessions per week for six weeks. Assessment will include single- and double-task walking speed, balance parameters and proprioception. Expected results: The hypothesis is that visual deprivation will stimulate the proprioceptive and vestibular systems to a greater extent, resulting in benefits for postural balance, walking and proprioception. The main hypothesis will be the improvement in the difference between single-task and double-task walking speed. Analyses will be conducted on an intention-to-treat basis, using statistical tests adapted to the nature of the variables. Conclusion: This study could highlight the value of temporary visual suppression as a therapeutic lever in stroke rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedStudy Start
First participant enrolled
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 19, 2027
October 1, 2025
September 1, 2025
2 years
April 25, 2025
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dual-task walking speed assessment
Speed (m/s) The dual-task walking speed assessment measures how well a person walks while simultaneously performing a cognitive or motor task. It helps identify changes in gait speed and stability when attention is divided, revealing potential fall risk or cognitive-motor interference.
6 weeks after subacute stroke
Secondary Outcomes (9)
Gait Speed assessment
3 to 6 monts after subacute stroke
Average step duration evaluation
3 to 6 monts after subacute stroke
Gait symmetry evaluation
3 to 6 monts after subacute stroke
Cycle duration variability evaluation
3 to 6 monts after subacute stroke
Single-task and double-task gait speed evaluation
3 to 6 monts after subacute stroke
- +4 more secondary outcomes
Study Arms (2)
Hidden Eyes
EXPERIMENTALTreadmill walking training with body weight reduced and eyes hidden
Open Eyes
NO INTERVENTIONTreadmill walking training with reduced body weight and open eyes.
Interventions
Patients will participate in walking rehabilitation sessions on a treadmill supported by a Lite Gait® harness. All treadmill sessions are consistent with regular rehabilitation sessions. A typical treadmill walking session will take place 3 times a week for 6 weeks, lasting 20 minutes. During the first minute, the speed of the treadmill is gradually increased until a comfortable speed is reached. From then on, the mask will be placed over the patient's eyes for 18 minutes at a constant, i.e. comfortable, speed. The last minute will be devoted to gradually decreasing the treadmill speed until it stops, and will also be performed without the mask.
Eligibility Criteria
You may qualify if:
- years of age or older,
- With a confirmed diagnosis of ischemic or hemorrhagic stroke in sub-acute phase (stroke less than 6 months old),
- With NIHSS scores between 1 and 15 and MoCA scores between 18 and 30
- With a physiotherapy prescription for post Stroke rehabilitation
- Able to walk for 20 min on a treadmill with weight reduction with pauses, able to maintain bipodal balance, able to maintain bipodal balance with eyes open and closed for 30 seconds,
- Having expressed free, informed and written consent
- Affiliated with a social security scheme.
You may not qualify if:
- Patients weighing over 200 kg (maximum weight permitted for use of the Lite Gait ®),
- Patients with impaired vision:
- Best corrected visual acuity below 5/10 on patient examination
- Homonymous lateral hemianopia, quadranopia.
- Inability to physically participate in intensive rehabilitation due to severe, unstabilized and comorbidities (heart, lung, kidney disease or diabetes), severe psychiatric disorders cancer active or under treatment.
- Patients participating in other interventional research,
- Pregnant or breast-feeding women,
- Patients under guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHR Metz-Thionville Hopital Legouest
Metz, 57085, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pauline AMSTUTZ
CHR Metz Thionville Hopital Legouest
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2025
First Posted
May 15, 2025
Study Start
June 4, 2025
Primary Completion (Estimated)
June 4, 2027
Study Completion (Estimated)
July 19, 2027
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share